Financial Highlights

Financial Highlights
2017 FQ1 YTD
3/31/2017
2016 FY
12/31/2016
2015 FY
12/31/2015
2014 FY
12/31/2014
2013 FY
12/31/2013
Balance Sheet ($000)
Cash and Cash Equivalents 8,123 7,368 6,763 6,426 4,987
Investments 112,500 112,657 112,557 109,549 100,050
Total Assets 148,942 148,579 147,841 144,865 133,980
Total Policy Reserves 77,449 76,174 77,043 74,115 71,671
Total Liabilities 100,918 100,527 102,958 102,108 100,508
Total Mezzanine Level Items 0 0 0 0 0
Equity Attributable to Parent Company 48,024 48,052 44,883 42,757 33,472
Total Equity 48,024 48,052 44,883 42,757 33,472
Equity before Unrealized Gains 45,994 46,366 43,423 39,169 31,945
Total Equity/ Total Assets(%) 32.24 32.34 30.36 29.52 24.98
Reserves/ Equity(x) 1.61 1.59 1.72 1.73 2.14
Income Statement ($000)
Total Policy Income 15,040 61,398 59,462 56,653 52,366
Net Investment Income 926 4,059 3,429 3,445 7,061
Realized Gain on Securities 160 831 536 478 1,124
Asset Management and Brokerage Fees 0 0 0 0 0
Total Revenue 16,278 66,893 64,050 64,392 61,160
Total Policy Expense 11,146 38,847 34,148 30,882 31,146
Underwriting & Other Expense 5,524 22,600 22,163 22,614 21,005
Total Expense 16,993 62,799 57,703 55,017 53,837
Net Income (316) 3,063 4,697 7,616 5,658
Net Income Attributable to Parent (316) 3,063 4,697 7,616 5,658
Operating Income after Taxes (420) 2,414 4,370 7,551 2,773
EBITDA (246) 5,749 8,038 11,376 9,712
Per Share Information ($)
Basic Book Value per Share 19.08 19.09 17.86 17.05 13.42
Book Value per Share before Unrealized Gains 18.27 18.42 17.28 15.62 12.81
Diluted EPS after Extraordinary (0.13) 1.22 1.87 3.04 2.28
EBITDA/ Share (0.10) 2.29 3.20 4.54 3.91
Operating EPS (0.17) 0.96 1.74 3.02 1.12
Price/ LTM Operating Earnings(x) 38.20 18.50 8.80 4.50 8.90
Common Dividends Declared per Share 0.05 0.18 0.16 0.12 0.10
Dividend Payout Ratio(%) NM 14.75 8.56 3.95 4.39
EPS after Extra Growth(%) NM (34.80) (38.50) 33.30 NM
Profitability (%)
ROAA (0.85) 2.03 3.19 5.38 4.18
Operating ROAA (1.13) 1.60 2.97 5.34 2.05
ROAE (2.63) 6.36 10.64 20.09 18.29
ROATCE (2.63) 6.36 10.64 20.09 18.29
Operating ROAE (3.50) 5.01 9.90 19.92 8.96
Investment Yield 3.61 3.99 3.36 3.50 7.82
Combined Ratio 106.30 94.59 89.95 87.39 93.43
P&C Stat Combined Ratio after Dividends NA NA NA NA NA
Reported Medical Care Ratio NA NA NA NA NA
Net Premiums Written/ Avg Equity(x) 1.34 1.28 1.37 1.54 1.74
Growth Rates and Trends (%)
Asset Growth 0.98 0.50 2.05 8.12 (1.28)
Equity Growth (0.23) 7.06 4.97 27.74 10.74
Net Written Premium Growth 0.63 1.88 3.75 8.17 3.45
Recurring Revenue Growth (0.24) 4.44 4.77 (0.04) 2.76
Net Income Growth NM (34.79) (38.33) 34.61 NM
Assets Five-year CAGR 2.43 2.25 1.55 1.97 1.41
Equity Five-year CAGR 4.43 4.79 0.53 0.76 (0.69)
Revenue Five-year CAGR 1.60 1.50 (1.59) (0.49) 0.15
Net Income Five-year CAGR NM NM 7.54 12.51 NM
Miscellaneous ($000)
Net Premiums Written 16,038 61,525 60,389 58,204 53,808
Gross Life Insurance in Force NA 208,420 208,172 212,068 209,909
Total Membership(actual) 0 0 0 0 0
Assets Under Management 0 0 0 0 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.
Copyright 2017, © S&P Global Market Intelligence  Terms of Use